Autopsy report · NCT02863263

Efficacy and Safety of MedifoamⓇ and BetafoamⓇ in Pressure Ulcer

“Difficulties in meeting recruitment target”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year before it stopped.
• 5 participants enrolled.
• Results were posted on the registry 1 year 10 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Mundipharma Pte Ltd.

Sponsor type

Industry

Conditions

Pressure Ulcer

Interventions

Foam Dressing; Foam Dressing with Povidone Iodine

Participants

5

Sites

1

Countries

South Korea

Trials that died the same way

• Subthreshold Laser Treatment in Intermediate Age-related Macular Degeneration With Nascent Geographic Atrophy Study
  “Difficulty with meeting recruitment targets” (97% match in meaning)
• Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis
  “Not able to meet recruitment targets” (91% match in meaning)
• Switch of Budesonide-formoterol Dry Powder Inhalers at Pharmacy in Norway
  “Target recruitment not reached” (85% match in meaning)
• Comprehensive Cognitive and Affective Intervention for Mild Cognitive Impairment (MCI) for Foreign-Born Arab Americans
  “Difficulties with recruitment” (84% match in meaning)
• ACTHAR Therapy for Central Nervous System Sarcoidosis
  “Difficulty with recruitment” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.